Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2013 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.
Br Med Bull. 2013;108:173-88. doi: 10.1093/bmb/ldt033. Epub 2013 Nov 7.
Br Med Bull. 2013.
PMID: 24211816
Review.
Targeted approaches to childhood cancer: progress in drug discovery and development.
Hirsch S, Marshall LV, Carceller Lechon F, Pearson AD, Moreno L.
Hirsch S, et al.
Expert Opin Drug Discov. 2015 May;10(5):483-95. doi: 10.1517/17460441.2015.1025745. Epub 2015 Apr 3.
Expert Opin Drug Discov. 2015.
PMID: 25840490
Review.
Item in Clipboard
Outcome of children and adolescents with central nervous system tumors in phase I trials.
Carceller F, Bautista F, Jiménez I, Hladun-Álvaro R, Giraud C, Bergamaschi L, Dandapani M, Aerts I, Doz F, Frappaz D, Casanova M, Morland B, Hargrave DR, Vassal G, Pearson ADJ, Geoerger B, Moreno L, Marshall LV.
Carceller F, et al.
J Neurooncol. 2018 Mar;137(1):83-92. doi: 10.1007/s11060-017-2698-z. Epub 2017 Dec 13.
J Neurooncol. 2018.
PMID: 29236237
Item in Clipboard
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study.
Carceller F, Bautista FJ, Jiménez I, Hladun-Álvaro R, Giraud C, Bergamaschi L, Dandapani M, Aerts I, Doz F, Frappaz D, Casanova M, Morland B, Hargrave DR, Marshall LV, Vassal G, Pearson AD, Geoerger B, Moreno L.
Carceller F, et al.
Eur J Cancer. 2016 Nov;67:130-140. doi: 10.1016/j.ejca.2016.08.008. Epub 2016 Sep 21.
Eur J Cancer. 2016.
PMID: 27662616
Item in Clipboard
Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience.
Morgenstern DA, Hargrave D, Marshall LV, Gatz SA, Barone G, Crowe T, Pritchard-Jones K, Zacharoulis S, Lancaster DL, Vaidya SJ, Chisholm JC, Pearson AD, Moreno L.
Morgenstern DA, et al.
J Pediatr Hematol Oncol. 2014 Apr;36(3):218-23. doi: 10.1097/MPH.0000000000000003.
J Pediatr Hematol Oncol. 2014.
PMID: 24322496
Item in Clipboard
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines.
Bax DA, Gaspar N, Little SE, Marshall L, Perryman L, Regairaz M, Viana-Pereira M, Vuononvirta R, Sharp SY, Reis-Filho JS, Stávale JN, Al-Sarraj S, Reis RM, Vassal G, Pearson AD, Hargrave D, Ellison DW, Workman P, Jones C.
Bax DA, et al.
Clin Cancer Res. 2009 Sep 15;15(18):5753-61. doi: 10.1158/1078-0432.CCR-08-3210. Epub 2009 Sep 8.
Clin Cancer Res. 2009.
PMID: 19737945
Item in Clipboard
Cite
Cite